Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"

Jonathan L. Halperin; John A. Savino

doi:10.1161/CIRCULATIONAHA.116.024837

Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e391-e392
Journal	Circulation
Volume	134
Issue number	18
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.116.024837
State	Published - 1 Nov 2016

Access to Document

10.1161/CIRCULATIONAHA.116.024837

Cite this

Halperin, J. L., & Savino, J. A. (2016). Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum". Circulation, 134(18), e391-e392. https://doi.org/10.1161/CIRCULATIONAHA.116.024837

Halperin, Jonathan L. ; Savino, John A. / Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum : Decision Making at the Lower End of the Risk Spectrum". In: Circulation. 2016 ; Vol. 134, No. 18. pp. e391-e392.

@article{5bb2fe750e4a4148af9ab57757612d20,

title = "Response by Halperin and Savino to Letter Regarding Article, {"}should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum{"}",

author = "Halperin, \{Jonathan L.\} and Savino, \{John A.\}",

year = "2016",

month = nov,

day = "1",

doi = "10.1161/CIRCULATIONAHA.116.024837",

language = "English",

volume = "134",

pages = "e391--e392",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "18",

}

Halperin, JL & Savino, JA 2016, 'Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum"', Circulation, vol. 134, no. 18, pp. e391-e392. https://doi.org/10.1161/CIRCULATIONAHA.116.024837

Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum". / Halperin, Jonathan L.; Savino, John A.
In: Circulation, Vol. 134, No. 18, 01.11.2016, p. e391-e392.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA2DS2-VASc 1 Conundrum

T2 - Decision Making at the Lower End of the Risk Spectrum"

AU - Halperin, Jonathan L.

AU - Savino, John A.

PY - 2016/11/1

Y1 - 2016/11/1

UR - https://www.scopus.com/pages/publications/84994618682

U2 - 10.1161/CIRCULATIONAHA.116.024837

DO - 10.1161/CIRCULATIONAHA.116.024837

M3 - Letter

C2 - 27799262

AN - SCOPUS:84994618682

SN - 0009-7322

VL - 134

SP - e391-e392

JO - Circulation

JF - Circulation

IS - 18

ER -

Halperin JL, Savino JA. Response by Halperin and Savino to Letter Regarding Article, "should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA₂DS₂-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? the CHA₂DS₂-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum". Circulation. 2016 Nov 1;134(18):e391-e392. doi: 10.1161/CIRCULATIONAHA.116.024837